Compliance with joint national committee 7 guidelines in hypertension management in a teaching institution

American Journal of Medical Quality

Volumn 22, Issue 4, 2007, Pages 251-258

  Jami, Prasuna ^a   Smith, Pamela ^c   Moningi, Shalini ^a   Moningi, Venkata ^d   Martin, Shelda A ^d   Rosencrance, Gregory ^a   Reyes, Bernardo J ^b,d  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b CHARLESTON AREA MEDICAL CENTER   (United States)

^c PFIZER INC   (United States)

^d West Virginia University ^*

Author keywords

Compliance; Guidelines; JNC 7; Teaching hospital

Indexed keywords

EID: 34547443966     PISSN: 10628606     EISSN: 1555824X     Source Type: Journal    
DOI: 10.1177/1062860607303293     Document Type: Article

References (25)

1. Rosenblatt RA, Cherkin DC, Schneeweiss R., Hart LG The content of ambulatory medical care in the United States: an interspecialty comparison. N Eng J Med. 1983 ; 309: 892-897.
2. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002 ; 288: 2981-2997.
3. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomized trials. Lancet. 2003 ; 362: 1527-1535.
4. Stockwell DH, Madhavan S., Cohen H., Gibson G., Alderman MH The determinants of hypertension awareness, treatment, and control in an insured population. Am J Public Health. 1994 ; 84: 1768-1774.
5. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003 ; 289: 2560-2572.
6. Franklin SS, Jacobs MJ, Wong ND, L'Italien GJ, Lapuerta P. Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives, analysis based on NHANES 3. Hypertension. 2001 ; 37 (3). 869-874.
7. DiTusa L., Luzier AB, Jarosz DE, Snyder BD, Izzo JL Treatment of hypertension in a managed care setting. Am J Manag Care. 2001 ; 7: 520-524.
8. Goldstein AO, Carey TS, Levis D., Madson S., Bernstein J. Variations in hypertension control in indigent rural primary care clinics in North Carolina. Arch Fam Med. 1994 ; 3: 514-519.
9. Jackson JH, Bramley TJ, Chiang TH, Jhaveri V., Frech F. Determinants of uncontrolled hypertension in an African-American population. Ethn Dis. 2002 ; 12: 53-57.
10. Pavlik VN, Hyman DJ, Vallbona C. Hypertension control in multiethnic primary care clinics. J Hum Hypertens. 1996 ; 10 (suppl 3). S19 - S23.
11. Meissner I., Whisnant JP, Sheps SG, et al. Detection and control of high blood pressure in the community: do we need a wake up call ? Hypertension. 1999 ; 34: 466-471.
12. Centers for Disease ControlNational Center for Health Statistics. Obesity, High Blood Pressure Impacting Many U.S. Adults Ages 55-64. 1 st ed. Hyattsville, MD: Government Printing Office; 2005.
13. Spranger CB, Ries AJ, Berge CA, Radford NB, Victor RG Identifying gaps between guidelines and clinical practice in the evaluation and treatment of patients with hypertension. Am J Med. 2004 ; 117 (1). 14-18.
14. Dahlof B., Sever PS, Poulter NR, et al, ASCOT Investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet. 2005 ; 366 (9489). 895-906.
15. Andros V., Egger A., Dua U. Blood pressure goal attainment according to JNC 7 guidelines and utilization of antihypertensive drug therapy in MCO patients with type 1 or type 2 diabetes. J Manag Care Pharm. 2006 ; 12 (4). 303-309.
16. Cheng JW, Kalis MM, Feiter S. Patient-reported adherence to guidelines of the Sixth Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Pharmacotherapy. 2001 ; 21 (7). 828-841.
17. Bramley TJ, Gerbino PP, Nightengale BS, Frech-Tamas F. Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations. J Manag Care Pharm. 2006 ; 12 (3). 239-245.
18. Navarro R., Rivera J., Rosado A., Ruiz H., Iriarte RI Compliance with current therapy guidelines in hypertensive patients at an emergency service [in Spanish]. Bol Asoc Med P R. 2004 ; 96 (4). 209-217.
19. Vivian EM Improving blood pressure control in a pharmacist-managed hypertension clinic. Pharmacotherapy. 2002 ; 22 (12). 1533-1540.
20. Clause SL, Hamilton RA Medicaid prescriber compliance with Joint National Committee VI Hypertension Treatment Guidelines. Ann Pharmacother. 2002 ; 36 (10). 1505-1511.
21. Xu KT, Moloney M., Phillips S. Economics of suboptimal drug use: cost-savings of using JNC-recommended medications for management of uncomplicated essential hypertension. Am J Manag Care. 2003 ; 9 (8). 529-536.
22. Ovbiagele B., Saver JL, Bang H., et al, VISP Study Investigators. Statin treatment and adherence to national cholesterol guidelines after ischemic stroke. Neurology. 2006 ; 66 (8). 1164-1170.
23. Helwig A., Bower D., Wolff M., Guse C. Residents find clinical practice guidelines valuable as educational and clinical tools. Fam Med. 1998 ; 30 (6). 431-435.
24. Echlin PS, Upshur RE, Markova TP Lack of chart reminder effectiveness on family medicine resident JNC-VI and NCEP III guideline knowledge and attitudes. BMC Fam Pract. 2004 ; 5: 14.
25. Mosen D., Elliott CG, Egger MJ, et al. The effect of a computerized reminder system on the prevention of postoperative venous thromboembolism. Chest. 2004 ; 125 (5). 1635-1641.